Andersson P, Karling P. Impact of treatment with immunomodulators and tumour necrosis factor antagonists on the incidence of infectious events in patients with inflammatory bowel disease. ujms [Internet]. 2022 Jan. 10 [cited 2026 Nov. 12];127(1). Available from: https://ujms.net/index.php/ujms/article/view/8167